1. Fonseca AC, Resende R, Oliveira CR, Pereira CM (2010) Cholesterol and statins in Alzheimer's disease: current controversies. Exp Neurol 223(2):282–293. doi:10.1016/j.expneurol.2009.09.013

2. Williams PT (2015) Lower risk of Alzheimer's disease mortality with exercise, statin, and fruit intake. J Alzheimers Dis 44(4):1121–1129. doi:10.3233/JAD-141929

3. Chou CY, Chou YC, Chou YJ, Yang YF, Huang N (2014) Statin use and incident dementia: a nationwide cohort study of Taiwan. Int J Cardiol 173(2):305–310. doi:10.1016/j.ijcard.2014.03.018

4. Simons M, Schwarzler F, Lutjohann D, von Bergmann K, Beyreuther K, Dichgans J, Wormstall H, Hartmann T et al (2002) Treatment with simvastatin in normocholesterolemic patients with Alzheimer's disease: A 26-week randomized, placebo-controlled, double-blind trial. Ann Neurol 52(3):346–350. doi:10.1002/ana.10292

5. Tong XK, Lecrux C, Rosa-Neto P, Hamel E (2012) Age-dependent rescue by simvastatin of Alzheimer's disease cerebrovascular and memory deficits. J Neurosci 32(14):4705–4715. doi:10.1523/JNEUROSCI.0169-12.2012

6. Li L, Cao D, Kim H, Lester R, Fukuchi K (2006) Simvastatin enhances learning and memory independent of amyloid load in mice. Ann Neurol 60(6):729–739. doi:10.1002/ana.21053

7. Roensch J, Crisby M, Nordberg A, Xiao Y, Zhang LJ, Guan ZZ (2007) Effects of statins on alpha7 nicotinic receptor, cholinesterase and alpha-form of secreted amyloid precursor peptide in SH-SY5Y cells. Neurochem Int 50(6):800–806. doi:10.1016/j.neuint.2007.02.001

8. Bliss TV, Collingridge GL (1993) A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361(6407):31–39. doi:10.1038/361031a0

9. Chen L, Yamada K, Nabeshima T, Sokabe M (2006) alpha7 Nicotinic acetylcholine receptor as a target to rescue deficit in hippocampal LTP induction in beta-amyloid infused rats. Neuropharmacology 50(2):254–268. doi:10.1016/j.neuropharm.2005.09.018

10. Leiser SC, Bowlby MR, Comery TA, Dunlop J (2009) A cog in cognition: how the alpha 7 nicotinic acetylcholine receptor is geared towards improving cognitive deficits. Pharmacol Ther 122(3):302–311. doi:10.1016/j.pharmthera.2009.03.009

11. Zhi WH, Zeng YY, Lu ZH, Qu WJ, Chen WX, Chen L, Chen L (2014) Simvastatin exerts antiamnesic effect in Abeta25-35 -injected mice. CNS Neurosci Ther 20(3):218–226. doi:10.1111/cns.12190

12. Skaletz-Rorowski A, Lutchman M, Kureishi Y, Lefer DJ, Faust JR, Walsh K (2003) HMG-CoA reductase inhibitors promote cholesterol-dependent Akt/PKB translocation to membrane domains in endothelial cells. Cardiovasc Res 57(1):253–264

13. Nakao T, Shiota M, Tatemoto Y, Izumi Y, Iwao H (2007) Pravastatin induces rat aortic endothelial cell proliferation and migration via activation of PI3K/Akt/mTOR/p70 S6 kinase signaling. J Pharmacol Sci 105(4):334–341

14. Mans RA, Chowdhury N, Cao D, McMahon LL, Li L (2010) Simvastatin enhances hippocampal long-term potentiation in C57BL/6 mice. Neuroscience 166(2):435–444. doi:10.1016/j.neuroscience.2009.12.062

15. Veyrac A, Besnard A, Caboche J, Davis S, Laroche S (2014) The transcription factor Zif268/Egr1, brain plasticity, and memory. Prog Mol Biol Transl Sci 122:89–129. doi:10.1016/B978-0-12-420170-5.00004-0

16. Endo A (2004) The discovery and development of HMG-CoA reductase inhibitors. 1992. Atheroscler Suppl 5(3):67–80. doi:10.1016/j.atherosclerosissup.2004.08.026

17. McTaggart SJ (2006) Isoprenylated proteins. Cell Mol Life Sci 63(3):255–267. doi:10.1007/s00018-005-5298-6

18. Eckert GP, Hooff GP, Strandjord DM, Igbavboa U, Volmer DA, Muller WE, Wood WG (2009) Regulation of the brain isoprenoids farnesyl- and geranylgeranylpyrophosphate is altered in male Alzheimer patients. Neurobiol Dis 35(2):251–257. doi:10.1016/j.nbd.2009.05.005

19. Li W, Cui Y, Kushner SA, Brown RA, Jentsch JD, Frankland PW, Cannon TD, Silva AJ (2005) The HMG-CoA reductase inhibitor lovastatin reverses the learning and attention deficits in a mouse model of neurofibromatosis type 1. Curr Biol 15(21):1961–1967. doi:10.1016/j.cub.2005.09.043

20. Xiu J, Nordberg A, Shan KR, Yu WF, Olsson JM, Nordman T, Mousavi M, Guan ZZ (2005) Lovastatin stimulates up-regulation of alpha7 nicotinic receptors in cultured neurons without cholesterol dependency, a mechanism involving production of the alpha-form of secreted amyloid precursor protein. J Neurosci Res 82(4):531–541. doi:10.1002/jnr.20658

21. Wang C, Chen T, Li G, Zhou L, Sha S, Chen L (2015) Simvastatin prevents beta-amyloid-impaired neurogenesis in hippocampal dentate gyrus through alpha7nAChR-dependent cascading PI3K-Akt and increasing BDNF via reduction of farnesyl pyrophosphate. Neuropharmacology 97:122–132. doi:10.1016/j.neuropharm.2015.05.020

22. Mann DM, Ponieman D, Montori VM, Arciniega J, McGinn T (2010) The Statin Choice decision aid in primary care: a randomized trial. Patient Educ Couns 80(1):138–140. doi:10.1016/j.pec.2009.10.008

23. Qamar W, Sultana S (2008) Farnesol ameliorates massive inflammation, oxidative stress and lung injury induced by intratracheal instillation of cigarette smoke extract in rats: an initial step in lung chemoprevention. Chem Biol Interact 176(2-3):79–87. doi:10.1016/j.cbi.2008.08.011

24. Yang R, Chen L, Wang H, Xu B, Tomimoto H, Chen L (2012) Anti-amnesic effect of neurosteroid PREGS in Abeta25-35-injected mice through sigma1 receptor- and alpha7nAChR-mediated neuroprotection. Neuropharmacology 63(6):1042–1050. doi:10.1016/j.neuropharm.2012.07.035

25. Yin J, Sha S, Chen T, Wang C, Hong J, Jie P, Zhou R, Li L et al (2015) Sigma-1 (sigma(1)) receptor deficiency reduces beta-amyloid(25-35)-induced hippocampal neuronal cell death and cognitive deficits through suppressing phosphorylation of the NMDA receptor NR2B. Neuropharmacology 89:215–224. doi:10.1016/j.neuropharm.2014.09.027

26. Sha S, Xu J, Lu ZH, Hong J, Qu WJ, Zhou JW, Chen L (2014) Lack of JWA Enhances Neurogenesis and Long-Term Potentiation in Hippocampal Dentate Gyrus Leading to Spatial Cognitive Potentiation. Mol Neurobiol. doi:10.1007/s12035-014-9010-4

27. Albers KM, Zhang XL, Diges CM, Schwartz ES, Yang CI, Davis BM, Gold MS (2014) Artemin growth factor increases nicotinic cholinergic receptor subunit expression and activity in nociceptive sensory neurons. Mol Pain 10:31. doi:10.1186/1744-8069-10-31

28. Ghedini PC, Avellar MC, De Lima TC, Lima-Landman MT, Lapa AJ, Souccar C (2012) Quantitative changes of nicotinic receptors in the hippocampus of dystrophin-deficient mice. Brain Res 1483:96–104. doi:10.1016/j.brainres.2012.09.021

29. Coelho DJ, Sims DJ, Ruegg PJ, Minn I, Muench AR, Mitchell PJ (2005) Cell type-specific and sexually dimorphic expression of transcription factor AP-2 in the adult mouse brain. Neuroscience 134(3):907–919. doi:10.1016/j.neuroscience.2005.04.060

30. Maurice T, Lockhart BP, Privat A (1996) Amnesia induced in mice by centrally administered beta-amyloid peptides involves cholinergic dysfunction. Brain Res 706(2):181–193

31. Aggleton JP, Hunt PR, Rawlins JN (1986) The effects of hippocampal lesions upon spatial and non-spatial tests of working memory. Behav Brain Res 19(2):133–146

32. Mans RA, McMahon LL, Li L (2012) Simvastatin-mediated enhancement of long-term potentiation is driven by farnesyl-pyrophosphate depletion and inhibition of farnesylation. Neuroscience 202:1–9. doi:10.1016/j.neuroscience.2011.12.007

33. Finlay-Schultz J, Canastar A, Short M, El Gazzar M, Coughlan C, Leonard S (2011) Transcriptional repression of the alpha7 nicotinic acetylcholine receptor subunit gene (CHRNA7) by activating protein-2alpha (AP-2alpha). J Biol Chem 286(49):42123–42132. doi:10.1074/jbc.M111.276014

34. Kihara T, Shimohama S, Sawada H, Honda K, Nakamizo T, Shibasaki H, Kume T, Akaike A (2001) alpha 7 nicotinic receptor transduces signals to phosphatidylinositol 3-kinase to block A beta-amyloid-induced neurotoxicity. J Biol Chem 276(17):13541–13546. doi:10.1074/jbc.M008035200

35. Blake MG, Boccia MM, Krawczyk MC, Baratti CM (2013) Hippocampal alpha7-nicotinic cholinergic receptors modulate memory reconsolidation: a potential strategy for recovery from amnesia. Neurobiol Learn Mem 106:193–203. doi:10.1016/j.nlm.2013.09.001

36. Kannan P, Buettner R, Chiao PJ, Yim SO, Sarkiss M, Tainsky MA (1994) N-ras oncogene causes AP-2 transcriptional self-interference, which leads to transformation. Genes Dev 8(11):1258–1269

37. Gu Z, Lamb PW, Yakel JL (2012) Cholinergic coordination of presynaptic and postsynaptic activity induces timing-dependent hippocampal synaptic plasticity. J Neurosci 32(36):12337–12348. doi:10.1523/JNEUROSCI.2129-12.2012

38. Kawamata J, Shimohama S (2011) Stimulating nicotinic receptors trigger multiple pathways attenuating cytotoxicity in models of Alzheimer's and Parkinson's diseases. J Alzheimers Dis 24(Suppl 2):95–109. doi:10.3233/JAD-2011-110173

39. Mozayan M, Chen MF, Si M, Chen PY, Premkumar LS, Lee TJ (2006) Cholinesterase inhibitor blockade and its prevention by statins of sympathetic alpha7-nAChR-mediated cerebral nitrergic neurogenic vasodilation. J Cereb Blood Flow Metab 26(12):1562–1576. doi:10.1038/sj.jcbfm.9600310

40. Si ML, Long C, Yang DI, Chen MF, Lee TJ (2005) Statins prevent beta-amyloid inhibition of sympathetic alpha7-nAChR-mediated nitrergic neurogenic dilation in porcine basilar arteries. J Cereb Blood Flow Metab 25(12):1573–1585. doi:10.1038/sj.jcbfm.9600232

41. Maelicke A, Schrattenholz A, Samochocki M, Radina M, Albuquerque EX (2000) Allosterically potentiating ligands of nicotinic receptors as a treatment strategy for Alzheimer's disease. Behav Brain Res 113(1-2):199–206

42. Colon-Saez JO, Yakel JL (2011) The alpha7 nicotinic acetylcholine receptor function in hippocampal neurons is regulated by the lipid composition of the plasma membrane. J Physiol 589(Pt 13):3163–3174. doi:10.1113/jphysiol.2011.209494

43. Abraham WC, Tate WP (1997) Metaplasticity: a new vista across the field of synaptic plasticity. Prog Neurobiol 52(4):303–323

44. Cheng Q, Yakel JL (2014) Presynaptic alpha7 nicotinic acetylcholine receptors enhance hippocampal mossy fiber glutamatergic transmission via PKA activation. J Neurosci 34(1):124–133. doi:10.1523/JNEUROSCI.2973-13.2014

45. Hunter BE, de Fiebre CM, Papke RL, Kem WR, Meyer EM (1994) A novel nicotinic agonist facilitates induction of long-term potentiation in the rat hippocampus. Neurosci Lett 168(1-2):130–134

46. Opazo P, Watabe AM, Grant SG, O'Dell TJ (2003) Phosphatidylinositol 3-kinase regulates the induction of long-term potentiation through extracellular signal-related kinase-independent mechanisms. J Neurosci 23(9):3679–3688

47. Thomas GM, Huganir RL (2004) MAPK cascade signalling and synaptic plasticity. Nat Rev Neurosci 5(3):173–183. doi:10.1038/nrn1346

48. Qin Y, Zhu Y, Baumgart JP, Stornetta RL, Seidenman K, Mack V, van Aelst L, Zhu JJ (2005) State-dependent Ras signaling and AMPA receptor trafficking. Genes Dev 19(17):2000–2015. doi:10.1101/gad.342205

49. Chen L, Miyamoto Y, Furuya K, Mori N, Sokabe M (2007) PREGS induces LTP in the hippocampal dentate gyrus of adult rats via the tyrosine phosphorylation of NR2B coupled to ERK/CREB [corrected] signaling. J Neurophysiol 98(3):1538–1548. doi:10.1152/jn.01151.2006

50. Wang Q, Zengin A, Deng C, Li Y, Newell KA, Yang GY, Lu Y, Wilder-Smith EP et al (2009) High dose of simvastatin induces hyperlocomotive and anxiolytic-like activities: The association with the up-regulation of NMDA receptor binding in the rat brain. Exp Neurol 216(1):132–138. doi:10.1016/j.expneurol.2008.11.016

51. Thornton C, Yaka R, Dinh S, Ron D (2003) H-Ras modulates N-methyl-D-aspartate receptor function via inhibition of Src tyrosine kinase activity. J Biol Chem 278(26):23823–23829. doi:10.1074/jbc.M302389200

52. Manabe T, Aiba A, Yamada A, Ichise T, Sakagami H, Kondo H, Katsuki M (2000) Regulation of long-term potentiation by H-Ras through NMDA receptor phosphorylation. J Neurosci 20(7):2504–2511

53. Meyer EM, Tay ET, Papke RL, Meyers C, Huang GL, de Fiebre CM (1997) 3-[2,4-Dimethoxybenzylidene]anabaseine (DMXB) selectively activates rat alpha7 receptors and improves memory-related behaviors in a mecamylamine-sensitive manner. Brain Res 768(1-2):49–56

54. Levin ED, Bettegowda C, Blosser J, Gordon J (1999) AR-R17779, and alpha7 nicotinic agonist, improves learning and memory in rats. Behav Pharmacol 10(6-7):675–680

55. Kihara T, Sawada H, Nakamizo T, Kanki R, Yamashita H, Maelicke A, Shimohama S (2004) Galantamine modulates nicotinic receptor and blocks Abeta-enhanced glutamate toxicity. Biochem Biophys Res Commun 325(3):976–982. doi:10.1016/j.bbrc.2004.10.132